News
PFE
24.88
-1.31%
-0.33
Option traders moderately bearish in Pfizer with shares down 1.25%
TipRanks · 6h ago
Will the Recent Pricing Deal With the Government Impact BMY's Sales?
NASDAQ · 8h ago
Pfizer Reports Patient Death In Marstacimab Hemophilia Extension Study
Benzinga · 9h ago
BridgeBio Has More Room To Run
Seeking Alpha · 9h ago
Midday Fly By: Wegovy weight loss pill approved, ServiceNow inks security deal
TipRanks · 10h ago
Pfizer Says Safety And Well-being Of Participants In Our Clinical Trials Remain Our Highest Priority, And We Are Committed To Transparency; Does Not Anticipate Any Impact To Safety For Patients Treated With Approved Marstacimab
Benzinga · 11h ago
Pfizer reports patient death in hemophilia trial for Hympavzi
Seeking Alpha · 12h ago
MSFT, CRM, ORCL: Why Evercore Names These 3 Software Stocks as ‘Top Picks for 2026’
TipRanks · 12h ago
'Pfizer discloses patient death in Hympavzi hemophilia trial'- Endpoints News
Benzinga · 12h ago
Pfizer patient in Hympavzi trial dies from stroke, Endpoints News reports
TipRanks · 12h ago
Bristol-Myers Squibb: Still Undervalued And Generating 4.65% Dividend Yield
Seeking Alpha · 13h ago
2026 Market Outlook: An Underappreciated Policy Shift Could Favor The S&P 493
Seeking Alpha · 13h ago
Novo Nordisk Shares Surge 7% In Tuesday Pre-Market After US FDA Approves Wegovy Pill
Benzinga · 17h ago
Pfizer (PFE) Valuation Check as Padcev–Keytruda Success and Obesity Deals Recast Its Post‑COVID Growth Story
Simply Wall St · 1d ago
Moderately bullish activity in Pfizer with shares up 0.14%
TipRanks · 1d ago
Bet on These Top-Ranked Healthcare ETFs Before 2025 Ends
NASDAQ · 1d ago
This Pharma Stock Had a Rough Year. Why One Analyst Thinks It Can Rise 250%.
Barron‘s · 1d ago
Government deals lift overhang on pharma group, says BofA
TipRanks · 1d ago
Weekly Report: what happened at PFE last week (1215-1219)?
Weekly Report · 1d ago
Should You Forget Novo Nordisk and Buy This Magnificent High-Yield Drug Stock Instead?
The Motley Fool · 1d ago
More
Webull provides a variety of real-time PFE stock news. You can receive the latest news about Pfizer through multiple platforms. This information may help you make smarter investment decisions.
About PFE
Pfizer Inc. is a research-based, global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment includes the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its oncology products include Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak and Talzenna. Its primary care products include Eliquis, Nurtec ODT/Vydura, Zavzpret, the Prevnar family, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix, Trumenba, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Abrilada, Cibinqo, Litfulo, Eucrisa, Velsipity, the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, Hympavzi, Sulperazon, Zavicefta, Octagam and others.